Apotex Health closes ~$1.5B IPO

Goodmans LLP served as lead issuer counsel to Apotex Health Corp. in connection with the closing of its oversubscribed and upsized ~$1.5 billion initial public offering, which is the largest ever life sciences IPO and one of the largest IPOs in Canadian history. 

The offering consisted of a treasury offering by Apotex of 35,416,666 common shares, for gross proceeds of $849,999,984 to Apotex, and a secondary offering by an affiliate of U.S. private equity firm SK Capital and others of 26,875,004 common shares, for gross proceeds of $645,000,096. The secondary offering included 8,125,000 common shares sold to the underwriters upon exercise of their over-allotment option, which was exercised in full. The common shares are listed on the Toronto Stock Exchange under the symbol "APTX".

Apotex is Canada's largest pharmaceutical company.